205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.89%
Negative revenue growth while QRVO stands at 4.69%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-14.65%
Negative gross profit growth while QRVO is at 4.06%. Joel Greenblatt would examine cost competitiveness or demand decline.
-17.85%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-18.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-14.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.94%
Negative EPS growth while QRVO is at 1.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-13.77%
Negative diluted EPS growth while QRVO is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.77%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.76%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
7.68%
Dividend growth of 7.68% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-26.17%
Negative OCF growth while QRVO is at 195.71%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-45.60%
Negative FCF growth while QRVO is at 344.01%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
92.58%
10Y revenue/share CAGR at 50-75% of QRVO's 158.85%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
35.39%
5Y revenue/share CAGR under 50% of QRVO's 115.76%. Michael Burry would suspect a significant competitive gap or product weakness.
43.56%
3Y revenue/share CAGR under 50% of QRVO's 91.83%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
131.20%
10Y OCF/share CAGR under 50% of QRVO's 1958.75%. Michael Burry would worry about a persistent underperformance in cash creation.
15.09%
Below 50% of QRVO's 66.54%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
19.89%
3Y OCF/share CAGR under 50% of QRVO's 106.78%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
812.98%
Net income/share CAGR at 75-90% of QRVO's 928.35%. Bill Ackman would press for strategic moves to boost long-term earnings.
520.08%
5Y net income/share CAGR 1.25-1.5x QRVO's 351.70%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
88.83%
Below 50% of QRVO's 286.49%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
63.37%
Below 50% of QRVO's 343.80%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
53.31%
5Y equity/share CAGR above 1.5x QRVO's 10.62%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
68.54%
3Y equity/share CAGR above 1.5x QRVO's 16.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
487.06%
Dividend/share CAGR of 487.06% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
99.82%
Dividend/share CAGR of 99.82% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
37.51%
Our short-term dividend growth is positive while QRVO cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-7.11%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
14.68%
Inventory growth well above QRVO's 6.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.41%
Positive asset growth while QRVO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.26%
BV/share growth above 1.5x QRVO's 0.66%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
14.39%
Debt growth far above QRVO's 0.01%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
0.70%
R&D dropping or stable vs. QRVO's 2.79%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-0.46%
We cut SG&A while QRVO invests at 2.35%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.